The U.S. health regulator pulls its authorization for GSK-Vir’s COVID-19 therapy in the U.S. The move comes as a blow as GlaxoSmithKline and Vir saw high demand for sotrovimab
The U.S. health regulator said on Tuesday GlaxoSmithKline and Vir Biotechnology’s antibody therapy was no longer authorized to treat COVID-19 in the U.S. due to an increase in the proportion of cases caused by the Omicron sub-variant.
The agency pulled its authorization for the therapy sotrovimab in much of the U.S. northeast last month. The highly contagious BA.2 coronavirus sub-variant is estimated to cause about three of every four COVID-19 cases in the U.S. now, according to government data.GlaxoSmithKline and Vir have said treatment with sotrovimab retains neutralizing activity against the BA.2 sub-variant, but others, including researchers from Columbia University, found it did not.
Last month, the companies said they were preparing a package of data in support of a higher dose for sotrovimab than the currently authorized 500 mg for the BA.2 sub-variant. The U.S. Food and Drug Administration’s move on Tuesday comes as a blow as GlaxoSmithKline and Vir saw high demand for sotrovimab after it became one of the few COVID-19 treatments shown to have worked against the Omicron variant.Our Morning Update and Evening Update newsletters are written by Globe editors, giving you a concise summary of the day’s most important headlines.
Canada Latest News, Canada Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Quebec extends mask mandate for month of April amid rise in COVID-19 hospitalizationsThe Quebec government said the province will maintain the mask mandate for indoor public spaces until at least the end of April due to a rise in COVID-19 cases and hospitalizations
Read more »
Springtime religious gatherings proceed in B.C. for first time since pandemic began | Globalnews.caWith the highly contagious Omicron subvariant BA.2 circulating, organizers are still concerned about COVID-19 spread.
Read more »
Legacy of long COVID: Experts point to hurdles in treatment, diagnosisNew research suggests that symptoms linked to long COVID could vary depending on which COVID-19 variant a person is infected with, but infectious disease experts say they are not yet convinced.
Read more »
Toronto's top doctor urges residents to continue wearing masks indoors amid sixth wave of pandemicToronto’s top doctor is urging residents to return to wearing masks in public indoor settings amid a rise in COVID-19 transmission in the city.
Read more »
9 cruise ships due to arrive in Victoria currently have COVID-19 cases on board: CDCNine of the 11 cruise ships due to arrive in Victoria this month currently have confirmed COVID-19 cases on board, according to the U.S. Centers for Disease Control and Prevention (CDC).
Read more »
Quebec reports seven more COVID-19 deaths and 57-patient rise in hospitalizationsQuebec reports 2,331 new COVID-19 cases, with 1,407 people in hospital, 69 in ICU and seven more deaths
Read more »